首页> 外文期刊>FEBS letters. >Loss of putative tumor suppressor EI24/PIG8 confers resistance to etoposide.
【24h】

Loss of putative tumor suppressor EI24/PIG8 confers resistance to etoposide.

机译:推定的肿瘤抑制因子EI24 / PIG8的丧失赋予对依托泊苷的耐药性。

获取原文
获取原文并翻译 | 示例
           

摘要

Expression of p53-target gene EI24/PIG8 is lost in invasive breast cancers, suggesting that EI24/PIG8 is a tumor suppressor that prevents tumor spreading, and partially mediates p53-attributed tumor suppressor activity. EI24/PIG8 also has pro-apoptotic activity indicating that loss of EI24/PIG8 may modulate sensitivity to chemotherapy. Here it is demonstrated that suppression of EI24/PIG8 in fibroblasts and breast cancer cells significantly inhibits the apoptotic response to etoposide treatment. These findings suggest that loss of EI24/PIG8 contributes significantly to resistance of cells to chemotherapeutic agents that function through p53, and identify the EI24/PIG8 status as a potentially new prognostic marker of chemotherapy responsiveness.
机译:p53靶基因EI24 / PIG8的表达在浸润性乳腺癌中丢失,表明EI24 / PIG8是一种肿瘤抑制因子,可阻止肿瘤扩散并部分介导p53归因的肿瘤抑制因子活性。 EI24 / PIG8还具有促凋亡活性,表明EI24 / PIG8的缺失可能会调节对化学疗法的敏感性。在此证明,抑制成纤维细胞和乳腺癌细胞中的EI24 / PIG8可显着抑制对依托泊苷治疗的凋亡反应。这些发现表明,EI24 / PIG8的缺失显着促进了细胞对通过p53发挥作用的化学治疗药物的耐药性,并将EI24 / PIG8的状态确定为化学疗法反应性的潜在新预后指标。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号